Published in Arch Surg on August 01, 1995
Hemorrhage after pancreatoduodenectomy. Ann Surg (1998) 2.35
Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00
The challenge of pancreatic anastomosis. Langenbecks Arch Surg (2008) 1.41
Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg (2004) 1.34
Oncological problems in pancreatic cancer surgery. World J Gastroenterol (2006) 1.08
Should Gastric Decompression be a Routine Procedure in Patients Who Undergo Pylorus-Preserving Pancreatoduodenectomy? World J Surg (2016) 1.06
Prospective randomized comparison between a new mattress technique and Cattell (duct-to-mucosa) pancreaticojejunostomy for pancreatic resection. World J Surg (2005) 1.05
Prospective, randomized trial on the effect of cyclic versus continuous enteral nutrition on postoperative gastric function after pylorus-preserving pancreatoduodenectomy. Ann Surg (1997) 1.02
Omental flap in pancreaticoduodenectomy for protection of splanchnic vessels. World J Surg (2005) 1.00
Delayed gastric emptying is associated with pylorus-preserving but not classical Whipple pancreaticoduodenectomy: a review of the literature and critical reappraisal of the implicated pathomechanism. World J Gastroenterol (2006) 0.99
Therapeutic strategies for the management of delayed gastric emptying after pancreatic resection. Langenbecks Arch Surg (2006) 0.90
The effect of pylorus removal on delayed gastric emptying after pancreaticoduodenectomy: a meta-analysis of 2,599 patients. PLoS One (2014) 0.80
Health Is Belonging: Lived Experiences during Recovery after Pancreaticoduodenectomy. ISRN Nurs (2012) 0.78
Pancreatic surgery: evolution and current tailored approach. Hepatobiliary Surg Nutr (2014) 0.77
Surgical anatomy of the innervation of pylorus in human and Suncus murinus, in relation to surgical technique for pylorus-preserving pancreaticoduodenectomy. World J Gastroenterol (2006) 0.77
Save the pylori. Ann Surg (2004) 0.75
Delayed Gastric Emptying after Pancreatic Surgery: Analysis of Factors Determinant for the Short-term Outcome. Front Surg (2016) 0.75
Is delayed gastric emptying so terrible after pylorus-preserving pancreaticoduodenectomy? Prevention and management. World J Gastroenterol (2006) 0.75
Pancreatoduodenectomy - preventing complications. Indian J Surg Oncol (2014) 0.75
Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison. HPB Surg (2009) 0.75
Proximal Roux-en-y Gastrojejunal Anastomosis with Pyloric Ring Resection Improves Gastric Emptying After Pancreaticoduodenectomy. J Gastrointest Surg (2016) 0.75
Preventing Delayed Gastric Emptying After Whipple's Procedure-Isolated Roux Loop Reconstruction With Pancreaticogastrostomy. Indian J Surg (2013) 0.75
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J (1972) 5.48
Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol (1971) 5.29
Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA. Br J Cancer (1973) 4.65
Mechanism of immunologically specific killing of tumour cells by macrophages. Nature (1972) 4.63
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Cooperation of immune lymphoid cells with macrophages in tumour immunity. Nature (1970) 4.01
The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour. Proc R Soc Lond B Biol Sci (1969) 3.54
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature (1974) 3.21
Gene for an immunoglobulin-binding protein from a group G streptococcus. J Bacteriol (1986) 2.95
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Two crystal structures of the B1 immunoglobulin-binding domain of streptococcal protein G and comparison with NMR. Biochemistry (1994) 2.67
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J (1971) 2.50
AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology (1999) 2.34
Laparoscopic cholecystectomy. The new 'gold standard'? Arch Surg (1992) 2.30
Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells. Transplantation (1971) 2.26
Treatment of a murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor. Cancer Res (1966) 2.16
Design and internal validation of an obstetric early warning score: secondary analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database. Anaesthesia (2013) 2.14
Rejoining of x-ray induced breaks in the DNA of leukaemia cells. Nature (1967) 2.09
The cellular immune response to primary sarcomata in rats. I. The significance of large basophilic cells in the thoracic duct lymph following antigenic challenge. Proc R Soc Lond B Biol Sci (1969) 1.97
Foetal "antigens" in cancer. Nature (1972) 1.95
Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery (1996) 1.88
Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Immunology (1972) 1.85
Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology (1997) 1.83
The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata. Br J Cancer (1973) 1.83
Evidence for an immunological reaction of the host directed against its own actively growing primary tumor. J Natl Cancer Inst (1966) 1.83
Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg (1990) 1.73
Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol (1997) 1.70
Compartment syndrome in experimental chronic obstructive pancreatitis: effect of decompressing the main pancreatic duct. Br J Surg (1994) 1.69
Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours. Br J Cancer (1980) 1.64
The interplay of lymphoid cells and macrophages in tumour immunity. Ann Inst Pasteur (Paris) (1972) 1.61
Combined endoscopic sphincterotomy and laparoscopic cholecystectomy in patients with choledocholithiasis and cholecystolithiasis. Ann Intern Med (1991) 1.52
Relative contributions of afferent vagal fibers to resistance to diet-induced obesity. Dig Dis Sci (2011) 1.48
Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery (2004) 1.45
Prospective evaluation of early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Am Surg (2000) 1.44
Thymocytes from mice immunized against an allograft render bone-marrow cells specifically cytotoxic. J Exp Med (1972) 1.44
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer (1977) 1.43
Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor. J Exp Med (1972) 1.43
Comparison of early postoperative results for laparoscopic versus standard open cholecystectomy. Surg Gynecol Obstet (1992) 1.41
The initial impact of rabbit hemorrhagic disease on European rabbit populations in South Australia. J Wildl Dis (1998) 1.40
The occurrence of tow types of cytotoxic lymphoid cells in mice immunised with allogeneic tumour cells. Transplantation (1970) 1.40
Hydrogen-deuterium exchange in the free and immunoglobulin G-bound protein G B-domain. Biochemistry (1994) 1.40
Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg (2007) 1.39
Technique for using pledgeted sutures in laparoscopic Nissen fundoplication. Surg Endosc (2001) 1.37
Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition. Immunology (1972) 1.36
Cytokines and acute pancreatitis. Gastroenterology (1996) 1.35
The functions of the macrophage in malignant disease. Annu Rev Med (1976) 1.35
Sequestration of macrophages in growing tumours and its effect on the immunological capacity of the host. Br J Cancer (1974) 1.34
Resolution of the components in the microsomal fraction of liver in the B-IV zonal centrifuge. Natl Cancer Inst Monogr (1966) 1.32
The role of immunoblasts in host resistance and immunotherapy of primary sarcomata. Adv Cancer Res (1970) 1.32
Spontaneous shedding of TSTA by viable sarcoma cells: its possible role in facilitating metastatic spread. Br J Cancer (1974) 1.32
Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata. Br J Cancer (1973) 1.30
Management of external gastrointestinal fistulas. Ann Surg (1978) 1.29
Effect of nucleic acids from immune lymphocytes on rat sarcomata. Nature (1967) 1.27
A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host. Br J Cancer (1973) 1.24
Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells? Cancer Res (1974) 1.24
Dopamine in models of alcoholic acute pancreatitis. Gut (1994) 1.23
Diurnal rhythmicity in intestinal SGLT-1 function, V(max), and mRNA expression topography. Am J Physiol Gastrointest Liver Physiol (2001) 1.22
Cellular resistance to tumours. Br Med Bull (1967) 1.22
Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology (1996) 1.21
Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure. Am Surg (2001) 1.20
Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg (2000) 1.20
Catalysis of a protein folding reaction: mechanistic implications of the 2.0 A structure of the subtilisin-prodomain complex. Biochemistry (1995) 1.20
DNA strand breakage in cells irradiated with x-rays. Nature (1969) 1.19
Pancreatic blood flow in cats with chronic pancreatitis. Gastroenterology (1992) 1.19
Cytotoxicity of murine peritoneal macrophages in tumour allograft immunity. Transplantation (1972) 1.17
Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system. Biomedicine (1973) 1.16
Assessment of stability differences in the protein G B1 and B2 domains from hydrogen-deuterium exchange: comparison with calorimetric data. Biochemistry (1995) 1.16
Pancreatic ductal and interstitial pressures in cats with chronic pancreatitis. Dig Dis Sci (1992) 1.15
Immunologically-mediated restraint of latent tumour metastases. Nature (1975) 1.14
Routes of spread of pathogens into the pancreas in a feline model of acute pancreatitis. Gut (1994) 1.13
Animal models of exocrine pancreatic cancer. Int J Colorectal Dis (2000) 1.13
The risk and accuracy of pancreatic biopsy. Am J Surg (1976) 1.13
Specific autostimulating factor released by lymphocytes. Nature (1971) 1.11
Prospects for immunotherapy of cancer: experience in experimental systems. Br Med J (1970) 1.11
Host-mediated mechanisms in the elimination of circulating cancer cells. Symp Fundam Cancer Res (1983) 1.11
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut (2006) 1.11
A factor preventing the development of lung metastases in rats with sarcomas. Nature (1973) 1.11
Mechanisms of organ selective tumour growth by bloodborne cancer cells. Br J Cancer (1988) 1.11
Immunologically specific activation of macrophages armed with the specific macrophage arming factor (SMAF). Proc Soc Exp Biol Med (1973) 1.10
The macrophage content of some human tumours. Cancer Lett (1975) 1.10
Surgical palliation for pancreatic cancer. Surg Clin North Am (1989) 1.10
CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br J Cancer (2004) 1.10
pKa measurements from nuclear magnetic resonance for the B1 and B2 immunoglobulin G-binding domains of protein G: comparison with calculated values for nuclear magnetic resonance and X-ray structures. Biochemistry (1997) 1.10
Paracellular glucose transport plays a minor role in the unanesthetized dog. Am J Physiol (1999) 1.09
The nature of the cytotoxic cells in lymph following primary antigenic challenge. Transplantation (1969) 1.09
Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers. Br J Cancer (1973) 1.08
Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res (1998) 1.07
Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements. Cryobiology (1977) 1.06
Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas (2000) 1.06
Energetics of folding subtilisin BPN'. Biochemistry (1992) 1.05
G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation. J Cell Physiol (2001) 1.05
Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg (2000) 1.05
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin. J Med Chem (1994) 1.04
Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma. Br J Cancer (1976) 1.04